Zimei Wu Selected Research

asulacrine

1/2018	Optimization of Weight Ratio for DSPE-PEG/TPGS Hybrid Micelles to Improve Drug Retention and Tumor Penetration.
8/2016	Integrated scientific data bases review on asulacrine and associated toxicity.
4/2016	Identification and characterization of in vivo metabolites of asulacrine using advanced mass spectrophotometry technique in combination with improved data mining strategy.
4/2015	Post-insertion of poloxamer 188 strengthened liposomal membrane and reduced drug irritancy and in vivo precipitation, superior to PEGylation.
10/2014	Physicochemical characterization of asulacrine towards the development of an anticancer liposomal formulation via active drug loading: stability, solubility, lipophilicity and ionization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zimei Wu Research Topics

Disease

35	Neoplasms (Cancer) 09/2022 - 01/2013
5	Breast Neoplasms (Breast Cancer) 06/2022 - 01/2013
5	Pancreatic Neoplasms (Pancreatic Cancer) 07/2021 - 10/2014
4	Parkinson Disease (Parkinson's Disease) 12/2019 - 01/2016
4	Osteosarcoma (Osteogenic Sarcoma) 02/2019 - 10/2017
4	Phlebitis 01/2018 - 04/2015
2	Colorectal Neoplasms (Colorectal Cancer) 09/2022 - 02/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2017
2	Cognitive Dysfunction 11/2019 - 01/2018
2	Brain Ischemia (Cerebral Ischemia) 01/2019 - 01/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 02/2018
2	Glioblastoma (Glioblastoma Multiforme) 11/2018 - 05/2017
1	Rupture 06/2022
1	Hemolysis 01/2022
1	Adenocarcinoma 07/2021
1	Liver Failure 03/2021
1	Infarction (Infarctions) 03/2019
1	Ischemic Stroke 03/2019
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2019
1	Non-alcoholic Fatty Liver Disease 02/2019
1	Cardiotoxicity 01/2019
1	Atherosclerosis 01/2019
1	Hemorrhoids 12/2018
1	Drug-Related Side Effects and Adverse Reactions 12/2018

Drug/Important Bio-Agent (IBA)

26	Pharmaceutical PreparationsIBA 09/2022 - 01/2013
20	Liposomes (Liposome)IBA 06/2022 - 08/2012
7	MicellesIBA 10/2021 - 05/2016
7	Gemcitabine FDA Link 07/2021 - 10/2014
6	Peptides (Polypeptides)IBA 01/2022 - 01/2018
5	asulacrineIBA 01/2018 - 10/2014
3	CurcuminIBA 07/2021 - 01/2018
3	PolymersIBA 01/2021 - 02/2019
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 01/2017
3	LactoferrinIBA 12/2019 - 01/2016
3	MicroRNAs (MicroRNA)IBA 11/2019 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 11/2019 - 01/2019
3	Hyaluronic Acid (Hyaluronan)IBA 10/2019 - 05/2016
3	rotigotine FDA Link 01/2018 - 01/2016
3	Antineoplastic Agents (Antineoplastics)IBA 01/2017 - 01/2016
2	Glutathione (Reduced Glutathione)IBA 02/2019 - 11/2018
2	ChitosanIBA 02/2019 - 01/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 02/2018
2	ProdrugsIBA 01/2017 - 01/2012
2	SolutionsIBA 04/2015 - 09/2010
1	Annexin A5IBA 09/2022
1	celastrolIBA 09/2022
1	Protons (Proton)IBA 06/2022
1	CalciumIBA 06/2022
1	AcidsIBA 06/2022
1	Contrast MediaIBA 03/2022
1	Orphan Nuclear ReceptorsIBA 02/2022
1	Hepatocyte Nuclear Factor 4IBA 02/2022
1	CaspasesIBA 02/2022
1	Oncogene Proteins (Oncogene Protein)IBA 02/2022
1	Biological ProductsIBA 02/2022
1	HydrogelsIBA 10/2021
1	pyrimidin-2-one beta-ribofuranosideIBA 06/2021
1	Cytidine DeaminaseIBA 06/2021
1	AmmoniaIBA 03/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	EnzymesIBA 01/2021
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2021
1	Biotin (Vitamin H)FDA Link 10/2020
1	AvidinIBA 10/2020
1	LigandsIBA 10/2020
1	Drug CombinationsIBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Cell-Penetrating PeptidesIBA 01/2020
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2020
1	Nanoparticle Drug Delivery SystemIBA 01/2020
1	AldehydesIBA 01/2020
1	Dopamine (Intropin)FDA LinkGeneric 12/2019
1	isoborneol (borneol)IBA 12/2019
1	AntagomirsIBA 11/2019
1	Protein Kinases (Protein Kinase)IBA 03/2019
1	Reducing AgentsIBA 02/2019
1	penetratinIBA 02/2019
1	BiguanidesIBA 02/2019
1	Interleukin-22 (IL-22)IBA 02/2019
1	Metformin (Glucophage)FDA LinkGeneric 02/2019
1	Terpenes (Terpenoids)IBA 01/2019
1	curdioneIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	Dosage Forms (Dosage Form)IBA 12/2018
1	AntipyreticsIBA 12/2018
1	Drug CarriersIBA 11/2018
1	Estrogens (Estrogen)FDA Link 11/2018
1	Estrogen ReceptorsIBA 11/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2018
1	poly(lactide) (polylactic acid)IBA 11/2018
1	Temozolomide (Temodar)FDA LinkGeneric 11/2018
1	EphrinsIBA 11/2018

Therapy/Procedure

12	Therapeutics 03/2022 - 10/2014
6	Drug Therapy (Chemotherapy) 01/2021 - 04/2015
1	Precision Medicine 03/2022
1	Photothermal Therapy 10/2021
1	Peritoneal Dialysis 03/2021
1	Intranasal Administration 12/2019